Related Experiment Video
Updated: Jun 26, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Methods and clinical biomarker discovery for targeted proteomics using Olink technology
Han Wang1,2, Tian Zhao1,2, Jingjing Zeng1,2
1Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Purpose:
This paper is to offer insights for designing research utilizing Olink technology to identify biomarkers and potential therapeutic targets for disease treatment.
Experimental Design:
We discusses the application of Olink technology in oncology, cardiovascular, respiratory and immune-related diseases, and Outlines the advantages and limitations of Olink technology.
Results:
Olink technology simplifies the search for therapeutic targets, advances proteomics research, reveals the pathogenesis of diseases, and ultimately helps patients develop precision treatments.
Conclusions:
Although proteomics technology has been rapidly developed in recent years, each method has its own disadvantages, so in the future research, more methods should be selected for combined application to verify each other.
Insights
This study explores Olink technology for identifying disease biomarkers and therapeutic targets. It highlights Olink
Area of Science:
- Proteomics and Biomarker Discovery
- Translational Research in Disease Treatment
Background:
- Olink technology offers a powerful platform for high-throughput proteomic analysis.
- Understanding disease pathogenesis requires comprehensive proteomic insights.
Purpose of the Study:
- To provide guidance for research design using Olink technology.
- To identify novel biomarkers and therapeutic targets for various diseases.
Main Methods:
- Discussion of Olink technology applications in oncology, cardiovascular, respiratory, and immune-related diseases.
- Analysis of the advantages and limitations of Olink technology.
Main Results:
- Olink technology streamlines the identification of therapeutic targets.
- Facilitates advancements in proteomics research and disease pathogenesis elucidation.
- Supports the development of precision treatments for patients.
Conclusions:
- While Olink technology is advanced, complementary methods are crucial for validation.
- Future research should integrate multiple proteomic approaches for robust findings.
Related Concept Videos
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
MALDI-TOF Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) is a commonly...

